Novartis Faces Setback with MorphoSys Acquisition as Safety Concerns Delay Key Drug Approval Plans
In a turn of events that could reshape Novartis' $2.9 billion acquisition of German biotech MorphoSys, the Swiss pharmaceutical giant ...
In a turn of events that could reshape Novartis' $2.9 billion acquisition of German biotech MorphoSys, the Swiss pharmaceutical giant ...
Nigerians have been cautioned by the National Agency for Food and Drugs Administration and Control (NAFDAC) regarding the usage of ...
The court rejects the Canadian drug convict's appeal in what could be an effort to increase pressure on Canada to ...
© 2020 The Lagos Today - Nkali.